Lena Edwards, MD, internist, Balance Health & Wellness Center, discusses stress and anxiety. Depression and anxiety are directly linked to HPA (hypothalamic-pituitary-adrenal axis) and increase in cortisol. SSRIs…
NEW YORK (Reuters Health) – Long-term treatment with the atypical antipsychotic asenapine prevents relapse of schizophrenia and is well tolerated, according to a report in the Journal of…
NEW YORK (Reuters Health) – A review published by the Cochrane Library concludes that artesunate should replace quinine as the standard treatment for severe malaria. Dr. David Sinclair,…
NEW YORK (Reuters Health) – Current evidence is still inconclusive as to whether patients with chronic kidney disease (CKD) may benefit from aggressive blood pressure control, according to…
NEW YORK (Reuters Health) – A single dose of zoledronate prevents bone loss associated with glucocorticoid therapy given for acute exacerbation of Crohn’s disease, a German team reports…
NEW YORK (Reuters Health) – An updated review of medications available for treating type 2 diabetes concludes that metformin continues to have the best benefit-to-harm profile, according to…
Vincent A. DeLeo, MD, Chairman, Department of Dermatology, St Luke’s – Roosevelt Hospital, New York, discusses sunscreens and FDA testing and labeling for photoprotection. The sunburn protection factor,…
Nanette B. Silverberg, MD, director of Pediatric and Adolescent Dermatology St. Luke’s – Roosevelt Hospital Center, New York, discusses melanoma and its increasing incidence. This has occurred in…
NEW YORK (Reuters Health) — Elderly women who were treated for urinary tract infections with trimethoprim-sulfamethoxazole were 3 times more likely to be hospitalized for hyperkalemia in the…
NEW YORK (Reuters Health) – Eradication rates of Helicobacter pylori in children are higher with sequential therapy compared with standard triple therapy, a Polish team reports in the…